U.S. FDA approves first mRNA flu shot from Moderna
The shot, mFlusiva, was given a traditional approval for adults aged 50 to 64, and an accelerated approval for those 65 years and older
· 8/6/2026, 6:45:26 AM· 2 min read
The shot, mFlusiva, was given a traditional approval for adults aged 50 to 64, and an accelerated approval for those 65 years and older
Read original story →
